 |
|
Clinical Correlates of Insomnia in Patients With Chronic Illness
David A. Katz, MD, MSc;
Colleen A. McHorney, PhD
Arch Intern Med. 1998;158:1099-1107.
ABSTRACT
Background Patients with chronic insomnia are more likely to develop affective disorders, cardiac morbidity, and other adverse health outcomes, yet many clinicians tend to trivialize the complaint of insomnia or to attribute it only to psychiatric causes.
Objectives To estimate the prevalence and longitudinal course of insomnia in patients with documented chronic medical illness and/or depression and to quantify the associations between specific chronic conditions and insomnia.
Methods The presence of mild or severe insomnia was based on responses to a sleep questionnaire completed by 3445 patients with at least 1 of 5 physician-identified chronic conditions (hypertension, diabetes, congestive heart failure, myocardial infarction, or depression) at baseline; a subsample of 1814 patients completed follow-up questionnaires at 2 years. Using multivariate techniques, we evaluated the relationship between chronic conditions, patient-reported comorbidities, and insomnia (complaints of initiating and maintaining sleep), adjusting for sociodemographics and health habits.
Results Sixteen percent of study patients had severe and 34% had mild insomnia at baseline. At 2-year follow-up, 59% (95% confidence interval, 55%-63%) of patients with mild insomnia and 83% (95% confidence interval, 78%-88%) of patients with severe insomnia at baseline still had sleep problems. Odds ratios corresponding to mild and severe insomnia for key risk factors were as follows: current depressive disorder, 2.6 and 8.2; subthreshold depression, 2.2 and 3.4; congestive heart failure, 1.6 and 2.5; obstructive airway disease, 1.6 and 1.5; back problems, 1.4 and 1.5; hip impairment, 2.2 and 2.7; and prostate problems, 1.6 and 1.4. The majority of insomnia-comorbidity associations observed at baseline persisted at 2-year follow-up.
Conclusions Patients with insomnia require follow-up, as the majority continue to be bothered by difficulty initiating and maintaining sleep. In addition to detecting affective disorders in patients with insomnia, clinicians should focus on medical conditions that disturb sleep, especially cardiopulmonary disease, painful musculoskeletal conditions, and prostate problems.
INTRODUCTION
INSOMNIA AFFECTS approximately one third of the general population and has a major impact on health.1-2 In the Alameda County study, the number of hours of sleep, combined with data on 6 other health practices, was a significant predictor of subsequent health and mortality.3-4 Patients with chronic insomnia are more likely to develop affective disorders,5-6 and sleep disturbance is associated with the persistence of depressive symptoms in older persons with depression.7 In addition to its psychological consequences, insomnia may worsen somatic symptoms.8 Insomnia has also been associated with clinically significant decrements in key quality-of-life domains, such as physical functioning and mental health in generally healthy, working adults9 and in patients with chronic conditions.10 Finally, insomnia (and associated daytime sleepiness) is associated with increased risk of automobile and work-related accidents11-12 and increased use of medical services.13-14 Thus, there is great need for the development of effective prevention and treatment strategies for this disorder.
The prevalence of insomnia tends to be higher in clinical populations than in the general population. Numerous investigators have demonstrated increased prevalence of insomnia in subjects with somatic diseases2, 9, 15-16 and in subjects with depressive symptoms.2, 5, 14, 17-18 Whereas a fair amount is known about sleep complaints in the general population, less is known about the epidemiology of insomnia and its longitudinal course among patients with chronic illness.19 In particular, previous studies have not examined the relationships between specific somatic conditions and insomnia in this population, while controlling for the presence of depressive symptoms.
To address these key issues, this study was designed (1) to estimate the prevalence and longitudinal course of insomnia in patients with documented chronic medical illness and/or depression and (2) to identify clinical risk factors associated with insomnia. The identification of risk factors and high-risk groups is an important strategy for the evaluation and management of chronic insomnia and can assist clinicians in targeting conditions that are most likely to promote or aggravate sleep problems.
METHODS
SAMPLE AND DATA COLLECTION
The data for these analyses were derived from the Medical Outcomes Study (MOS), a 4-year observational study of health outcomes for patients with chronic medical and psychiatric conditions. Details on study design and objectives have been extensively reported20-25 and are briefly summarized here. The MOS was conducted in 3 cities: Boston, Mass; Chicago, Ill; and Los Angeles, Calif. In each city, patients and physicians were sampled from 5 practice settings differing in organization, physician specialty mix, and payment arrangement. From these health care systems, 523 clinicians trained in family practice, general internal medicine, cardiology, endocrinology, psychiatry, and clinical psychology were sampled. Study participants were English-speaking adults who had had an office visit with an enrolled MOS clinician during 9-day screening periods in February to November 1986. Patients were asked to complete a brief, standardized, self-report questionnaire that gathered information on chronic disease, depressive symptoms, sociodemographic characteristics, and general health status.
Data from standardized physician-completed forms were used to identify patients with 5 medical tracer conditions (hypertension, diabetes, congestive heart failure, recent myocardial infarction, and depression).20-25 A 2-stage process, involving a short form of the Center for Epidemiological Studies Depression Scale26 included in the patient questionnaire and the National Institute of Mental Health Diagnostic Interview Schedule,25 was used to identify patients with depression and to stage the severity.25-26 Current depressive disorder was defined on the basis of criteria from the Diagnostic and Statistical Manual of Mental Disorders, Third Edition,27 for lifetime major depression or dysthymia and having had an unremitted episode of major depression or period of dysthymia during the last 12 months; patients with depressive symptoms who did not satisfy this definition were considered to have subthreshold depression.28
Inclusion in the longitudinal panel component of the MOS was determined by a combination of criteria based on relative severity of the chronic medical and psychiatric tracer conditions and active participation in baseline data collection.20 Enrollment criteria for the longitudinal component of the study were met by 4842 patients. From among the 4842 eligible patients, 2349 were selected for longitudinal follow-up in the MOS. The sample for the cross-sectional analysis reported herein is 3445 panel-eligible patients with chronic medical and psychiatric conditions who completed a self-administered patient assessment questionnaire by mail, after enrollment into the study.29-31 The sample for the longitudinal analyses reported herein is 1814 panel patients who completed both the baseline patient assessment questionnaire and the 2-year follow-up questionnaire.29
MEASURES OF SLEEP
The MOS compiled 12 sleep items that represented a synthesis of previous measures and the addition of some new items.32 Based on the results of 2 pilot studies, the final sleep battery included items that assessed the following 5 sleep domains: initiation and maintenance of sleep, respiratory problems during sleep, quantity of sleep, perceived adequacy of sleep, and daytime somnolence. Sleep items were collected by self-administered mail survey; all items used a 6-point Likert scale, with responses ranging from "all of the time" to "never." For the purpose of this analysis, insomnia was defined as the complaint of difficulty initiating or maintaining sleep, a definition used in other epidemiological investigations of insomnia.16, 33 Mild insomnia was defined by responses indicating difficulty in initiating or maintaining sleep during the preceding 4 weeks "some" or "a good bit" of the time; severe insomnia was defined by difficulty in initiating or maintaining sleep "most" or "all" of the time. The MOS sleep questions inquired into sleep during the preceding 4 weeks and thus were suitable for detecting chronic insomnia.34
In addition to the 5 MOS medical and psychiatric tracer conditions, 19 medical conditions comorbid to the tracer conditions were identified by means of data from the MOS health examination. The health examination (standardized medical history and clinical examination) was independently conducted by specially trained MOS medical staff.21, 29, 35-36 These comorbidities included anemia, coronary artery disease (ie, angina, history of myocardial infarction that occurred longer than 12 months ago), obstructive airway disease (ie, asthma, chronic obstructive pulmonary disease), gastrointestinal tract disorders (ie, inflammatory bowel disease, functional bowel disturbance, peptic ulcer), genitourinary tract disorders (ie, prostate disease, kidney or bladder infections within the preceding 6 months), joint disorders (ie, hip impairment, osteoarthritis, rheumatoid arthritis), acute back pain or sciatica (within the preceding 6 months), and general musculoskeletal complaints. Patients with angina who had had a myocardial infarction or congestive heart failure were grouped with the latter tracer conditions.
MEASURES OF POTENTIAL CONFOUNDERS
All data on sociodemographic variables (ie, age, sex, race, education, income, and marital status) and health habit variables (ie, smoking, alcohol use, exercise frequency, and body mass index) variables were obtained from questionnaire responses elicited on entry into the study. Alcohol and smoking status were assessed by a 3-point scale (eg, no history of use, past user, current user). Frequency of exercise was assessed with the question "How often do you exercise?" with the use of a 6-point Likert scale, with responses ranging from "daily or almost daily" to "almost never or never." Body mass index was computed from patient-reported weight and height.
STATISTICAL ANALYSIS
We used logistic regression to identify chronic conditions and comorbidities associated with insomnia at baseline and at 2-year follow-up. Because we suspected that some conditions or comorbidities might be associated only with mild but not severe insomnia, our model included mild and severe insomnia as dependent variables (vs no insomnia). The baseline data allow for cross-sectional analysis of the relationship between clinical conditions and insomnia, whereas the follow-up data enable assessment of whether these relationships persist over time. The independent variables of interest were physician-identified conditions and patient-reported comorbidities, which were assessed at baseline. Of the latter, we selected comorbidities that were suspected of influencing sleep on the basis of previous knowledge 8, 37 and that were significantly associated with insomnia at the P .25 level in bivariate analysis.38 Patients with chronic comorbidities of similar cause were grouped together (eg, asthma and chronic obstructive pulmonary disease). As all patients in the current study had 1 of the 5 physician-identified conditions, we used mild hypertension39 as the reference group in our multivariate analysis.
We adjusted for sociodemographic characteristics, health habits, and study location. To account for nonlinear effects, we included 3 dummy variables for age: 40 to 55, 56 to 65, and older than 65 years (age younger than 40 years was the holdout category). Similarly, we included 2 dummy variables for education: less than 12 years and exactly 12 years (greater than 12 years was the holdout category). Categories with sparse data and those judged to be similar, on the basis of logistic regression coefficients obtained from bivariate analyses, were collapsed. In addition, we checked 2-way interaction terms between depression (clinical and subthreshold) and chronic medical conditions to determine whether the effects of depression were different for those with vs those without chronic medical conditions.
We present the regression results in 2 ways. First, we computed odds ratios and corresponding 95% confidence intervals for each chronic condition and comorbidity group. Second, we generated predicted probabilities of mild and severe insomnia, adjusting for all covariates in the model, and averaged them for each chronic condition and comorbidity group. All regression analyses were performed with the MLOGIT procedure in STATA 4.0.40
RESULTS
The demographic and clinical characteristics of the MOS study sample that forms the basis of this analysis are shown in Table 1. Fourteen percent had 2 or more clinician-diagnosed medical conditions, and 37% had a concomitant depressive disorder (or subthreshold depression). On the basis of our working definition of insomnia, 16% of study patients had severe and 34% had mild insomnia at baseline. Of the remaining 50% of patients, a substantial fraction had symptoms of sleep disturbance but did not satisfy our definition of insomnia. Table 2 lends support to the validity of the definition of insomnia used in this study. Patients in the mild and severe categories reported sleeping 6.9 and 6.0 hours per night on average, compared with 7.3 hours per night in those without insomnia. Similarly, patients with increasing severity of insomnia were more likely to report daytime somnolence and taking longer than 30 minutes to fall asleep, and were less likely to report adequate sleep.
|
|
|
|
Table 1. Patient Characteristics in Baseline Sample and Longitudinal Panel
|
|
|
|
|
|
|
Table 2. Validity of Classification of Insomnia Severity
|
|
|
Bivariate analyses of sociodemographic variables showed that advanced age (ie, >65 years), female sex, nonwhite race, less than 12 years of education, being unmarried (ie, single, separated, or divorced), and low income (ie, <200% of poverty level) were highly associated with insomnia (P.001). Analysis of health habit variables showed that patients with mild or severe insomnia were more likely to be infrequent exercisers than were patients without insomnia (P=.05). The associations between insomnia and sex, race, and educational status remained significant in multivariate analysis; advanced age approached statistical significance after adjusting for chronic conditions (P=.07). No significant trends were observed for smoking status, alcohol use, or body mass index.
Multivariate regression analyses examining the association between physician-identified conditions and patient-reported comorbidities and insomnia at baseline are summarized in Table 3. The main results of the baseline analysis are as follows: (1) current depressive disorder and subthreshold depression were most strongly associated with insomnia; (2) among cardiopulmonary disorders, congestive heart failure and obstructive airway disease were significantly associated with both mild and severe insomnia; angina pectoris and myocardial infarction were associated only with mild insomnia; (3) among rheumatological disorders, back pain and hip impairment were associated with mild and severe insomnia at baseline; osteoarthritis was associated only with mild insomnia (and approached statistical significance for severe insomnia); (4) among gastrointestinal tract disorders, peptic ulcer disease was significantly associated with severe insomnia only; and (5) among genitourinary disorders, prostate problems were associated with mild insomnia. Two-way interaction terms between particular medical conditions and depression were not significant, suggesting that the effect of depression was similar across conditions.
|
|
|
|
Table 3. Clinical Risk Factors Associated With Mild and Severe Insomnia at Baseline*
|
|
|
To evaluate the magnitude of any observed associations between specific conditions and each grade of insomnia, we computed predicted probabilities of insomnia. Even in the absence of a depressive disorder, a substantial proportion of patients with specific medical comorbidities had mild or severe insomnia (Figure 1, left). Patients with depression, however, were more likely to have severe insomnia than were nondepressed patients (Figure 1, right).
|
|
|
|
Figure 1. Predicted probabilities of insomnia at baseline for physician-identified chronic conditions and selected patient-reported comorbidities, adjusted for sociodemographic variables, health habits, other conditions and comorbidities. Results are shown separately for patients without depressive symptoms (left) and those with depressive symptoms (right). Sleep status was missing for 177 patients, who were excluded from analysis. DM indicates diabetes mellitus; MI, myocardial infarction; CHF, congestive heart failure; ANG, angina pectoris; HIP, hip impairment; PRO, prostate problems; and OAD, obstructive airway disease.
|
|
|
At 2-year follow-up, 59% (95% confidence interval, 55%-63%) of patients with mild insomnia and 83% (95% confidence interval, 78%-88%) of patients with severe insomnia at baseline still had sleep problems, whereas a substantial proportion showed improvement (Figure 2). Among patients without insomnia at baseline, 21% and 3% developed mild and severe insomnia at 2-year follow-up, respectively. As shown in Table 4 (columns 2 and 3), the majority of associations observed at baseline persisted at 2-year follow-up; for some comorbidities (ie, obstructive airway disease and peptic ulcer disease), the odds ratios were similar to those at baseline but were no longer statistically significant. When we repeated the above analysis controlling for insomnia at baseline, however, the disease-insomnia associations that we observed in the baseline analysis were largely attenuated by the effects of previous sleep status (Table 4, columns 4 and 5).
|
|
|
|
Figure 2. Proportion of Medical Outcomes Study patients in each sleep category at 2-year follow-up, grouped by insomnia status at baseline. Sleep data were missing for 116 patients, who were excluded from analysis.
|
|
|
|
|
|
|
Table 4. Clinical Risk Factors Associated With Mild and Severe Insomnia at 2-Year Follow-up*
|
|
|
The relationship between change in comorbid conditions and change in insomnia status is less clear than that between comorbid conditions and insomnia at baseline. Table 5 shows that a greater percentage of patients who developed hip impairment, osteoarthritis, and peptic ulcer disease reported new or worsened insomnia, compared with those who did not develop these conditions (columns 2 and 3). Similarly, a greater percentage of patients who had resolution of a given comorbid condition reported improvement of insomnia compared with patients who reported no resolution of that condition (columns 4 and 5), although none of these differences was statistically significant. For example, 42% of patients who reported resolution of depression, vs 32% of patients who reported persistent depression, experienced improvement of insomnia at 2-year follow-up.
|
|
|
|
Table 5. Relationship Between Development (Resolution) of Comorbid Conditions and the Onset or Worsening (Improvement or Resolution) of Insomnia at 2-Year Follow-up*
|
|
|
Some attrition was observed in the longitudinal patient panel (n=2304). Patients in the panel who completed the 2-year follow-up questionnaire were more likely to be male, to be white, to have greater education and income, and to be more likely to be married and employed (Table 1). Clinically, patients in the longitudinal analytic sample were less likely to have congestive heart failure (8% vs 14%) or clinical depression (18% vs 25%). Thus, the sample on which longitudinal analyses are based is biased toward patients with higher socioeconomic status and with a lower burden of comorbidity. The effect of this bias on results reported in Table 4 would be to underestimate the impact of clinical risk factors associated with insomnia at 2-year follow-up.
COMMENT
Our findings extend the results of other investigators by demonstrating that several chronic medical conditions are associated with insomnia after controlling for depression. In addition, there was no significant association between age and insomnia after controlling for the presence of chronic conditions, as reported by other investigators.15, 41 As in previous population-based surveys, female sex14, 16, 18 and low educational status9, 18 were significantly associated with insomnia; in contrast to other studies,18 our analysis suggested that nonwhites were more likely than whites to report insomnia. About half of the patients in our study sample, which included patients with chronic medical and/or psychiatric conditions, reported frequent problems initiating or maintaining sleep; this proportion exceeds community-based prevalence estimates in the 15% to 35% range, using various definitions.5, 42
It is noteworthy that the majority of patients with insomnia at baseline still had sleep problems at follow-up, which has been reported by others.33, 43 For example, Hohagen et al43 showed that 75% and 52% of patients with severe insomnia at baseline had moderate to severe insomnia at 4 months and 2 years of follow-up. Moreover, previous insomnia has been shown to be an important predictor of current insomnia, which we confirmed in our longitudinal data.16 In patients with chronic conditions, the need for vigilance in detecting insomnia is demonstrated by the finding that 23% of patients developed new-onset mild or severe insomnia at 2-year follow-up; this compares with a 6% 1-year rate of incident insomnia in a population-based sample.5
Our analysis confirms the strong association between poor sleep and depression, which has also been documented in clinical studies19 and in population studies.2, 5, 7, 41, 44 Although affective disorders play a prominent role in patients with insomnia, we have demonstrated that multiple medical conditions are independently associated with insomnia, especially those characterized by cardiopulmonary symptoms, pain during the hours of sleep, and frequent nocturnal micturition.16, 45 Because insomnia often stems from a complex mix of contributory causes, it is essential for clinicians to target both psychological and medical risk factors that are most strongly associated with insomnia and those that are potentially modifiable. We will describe the relationships between specific medical conditions and insomnia in more detail below.
Our finding that patients with cardiovascular disease (ie, angina, congestive heart failure, or myocardial infarction) are more likely to have insomnia can be explained by several pathophysiological mechanisms. Patients with angina may suddenly awaken with pain during sleep,46 often during rapid eye movement sleep, on account of fluctuations in cardiac rate47; in addition, an increased frequency of sleep-disturbed breathing has been reported in patients with angina pectoris.48 Severe congestive heart failure has been associated with sleep-disturbed breathing (eg, Cheyne-Stokes respiration, obstructive sleep apnea) and may cause disruption of sleep on account of paroxysmal nocturnal dyspnea. Alternatively, patients with insomnia tend to be predisposed to cardiovascular problems. Specifically, people who sleep less than 6 hours per night have an increased occurrence of ischemic chest pain.49
Our results confirm the importance of coexisting obstructive airway disease as a risk factor for insomnia. Others have shown that patients with chronic obstructive pulmonary disease are more likely to have sleep problems than population-based controls50; in addition, wheezing and increased sputum production are significant predictors of the complaint of difficulty initiating or maintaining sleep.51 In patients with chronic obstructive pulmonary disease, arousals during sleep may be increased because of elevated arterial carbon dioxide concentration; moreover, oxygen desaturation typically worsens during rapid eye movement sleep and during snoring periods.42, 52 In persons with asthma, sleep efficiency tends to improve after symptoms are well controlled.53 However, medications used to treat obstructive airway disease (eg, inhaled  -agonists, theophylline, and systemic corticosteroids) may also worsen sleep patterns.
AMONG THE other disorders that we examined, painful musculoskeletal conditions (ie, osteoarthritis, hip impairment, back pain)9, 15-16,54 and prostate problems were associated with insomnia. Elderly people with osteoarthritis have been shown to experience more superficial sleep than age- and sex-matched controls.55 We suspect that the negative effect of prostate disorders (eg, benign prostatic hypertrophy) on sleep was mediated by the occurrence of nocturia, which may cause frequent awakening and difficulty in getting back to sleep.45, 56 Alternatively, others have suggested that a large proportion of the awakenings that patients attribute to nocturia were directly related to sleep apnea or other primary sleep disorders.57 In addition, peptic ulcer disease was associated with a nearly 2-fold increased risk of severe insomnia and may be a marker for concomitant gastroesophageal reflux disease, which increases arousals from sleep.42, 54
Insomnia has been linked to a host of other conditions, including irritable bowel syndrome,58 chronic renal failure,59 severe liver disease, dermatitis, and neurological disease (eg, stroke, Parkinson disease, epilepsy)47 and psychiatric disorders (eg, schizophrenia, personality disorders, dementia),60 which were either not sufficiently prevalent in our study sample or not specifically captured by MOS health questionnaires. Although these latter conditions were not implicated in our analysis, clinicians should be alert for their presence in patients with insomnia.
The limitations of this study deserve comment. Sleep problems were assessed by self-report and were not confirmed with polysomnographic measurements. For the time frame of the MOS sleep questions (4 weeks), it is doubtful that polysomnography would have provided a true criterion standard, as patients with insomnia have high night-to-night variability in the quality of their sleep.61 Moreover, the magnitude of differences between persons with insomnia and controls is often unremarkable, and many persons with self-identified insomnia do not demonstrate objective sleep abnormalities on polysomnography.62 Although no attempt was made to validate our findings in a sleep laboratory, data obtained from the patients regarding other measures of sleep appear to verify the existence of sleep problems. It should be noted, however, that some measures of self-reported sleep (ie, amount of sleep, number of arousals) tend to be underestimated, and other measures (ie, amount of time required to get to sleep) tend to be overestimated by patients, in comparison with laboratory data.63-64
Another limitation is the absence of data on drug use and its timing in relationship to sleep complaints. Many of the drugs used for treatment of the chronic conditions in MOS participants are associated with sleep disturbance and thus could confound the relationship between specific diagnoses and insomnia. For example, antihypertensives (eg, -blockers, clonidine, reserpine, diuretics), sympathomimetics (eg, terbutaline sulfate, albuterol sulfate), xanthine derivatives (theophylline, caffeine), and antidepressants (eg, serotonin-selective reuptake inhibitors) have all been implicated as causes of insomnia.54, 65-66 Moreover, occult caffeine intake from over-the-counter products has been associated with increased difficulty falling asleep in the elderly.54 Another consideration is the presence of residual confounding with respect to smoking and alcohol drinking status, both of which have been associated with snoring67 and sleep disturbance.65, 68 However, our results did not change when we used more detailed, 11-category versions of smoking and alcohol history variables in the MOS database.
In contrast to the significant associations between comorbid conditions and insomnia at baseline, the associations between change in comorbid conditions and change in insomnia status at 2-year follow-up were weak. This finding may be attributable to several factors. First, most of the questions on comorbidity asked whether the patient had experienced that condition at any time during the 2-year follow-up period, which did not necessarily coincide with the period to which the questions on sleep applied. Furthermore, the MOS was not explicitly designed to measure change in chronic disease, and the assessments were taken at too long an interval to prove ideal for the purpose at hand. Second, the power to detect significant associations was weak, as the number of patients who reported a change in each comorbid condition during follow-up was much smaller than the number reporting the presence of each condition at baseline. However, we observed trends that supported expected relationships (for all conditions except back pain): (1) patients with resolved comorbid conditions reported more improvement in insomnia than those without resolution and (2) patients who developed comorbid conditions reported new or worsened insomnia more often than those who did not develop the comorbid condition.
Interpretation of the above findings should account for the nature of the study sample. Because all patients in the study sample had chronic conditions, condition-specific odds ratios were computed relative to mild hypertension, which was selected as the reference group. It is noteworthy that persons with sleep apnea are more likely to be hypertensive69 and sleep complaints may be more common in hypertensive subjects than in nonhypertensive subjects15; however, others have not observed this latter association.9 Thus, it is likely that the associations between chronic conditions (other than hypertension) and insomnia in the current study would have been even stronger had the reference group been composed of patients without any chronic conditions. Finally, that the MOS only sampled patients with 5 chronic conditions who were insured and had a continuous relationship with a provider in 3 large urban areas limits generalizability.
Physician assessment of sleep history has been demonstrated to be poor compared with the assessment of other health behaviors,70 and there is a tendency for many clinicians to trivialize the complaint of insomnia.12 A possible explanation for this finding is that asking about sleep often discloses a panoply of potential contributory causes that many busy clinicians feel ill-prepared to handle. The consequences of ignoring insomnia can be serious, however, as patients with chronic insomnia are more likely to develop affective disorders,5 cardiac morbidity,49 and other adverse health outcomes.10
Our analysis demonstrates that several medical conditions have an independent association with insomnia, after controlling for depression. In addition to detecting affective disorders, we recommend that clinicians focus their evaluation of insomniac patients on target medical conditions that disturb sleep, especially cardiopulmonary disease, painful musculoskeletal conditions, and prostate disorders. Underlying conditions should be treated with medications not known to disturb sleep, or, if this is not possible, such medications should be administered at times that are likely to cause minimal sleep disruption. Finally, clinicians should be alert for sleep problems in patients with chronic conditions, as a sizable fraction develop new-onset insomnia. Future research should address whether more aggressive treatment of underlying diseases associated with insomnia leads to improved sleep and reduced need for hypnotic medications.
AUTHOR INFORMATION
Accepted for publication November 17, 1997.
Presented at the Society of General Internal Medicine Annual Meeting, Washington, DC, May 3, 1996.
We thank Ruth Benca, MD, PhD, and Khin Mae Hla, MD, MHS, for their critical review of the manuscript.
Reprints: David A. Katz, MD, MSc, Section of General Internal Medicine, Suite 100, 2870 University Ave, Madison, WI 53705.
From the Departments of Medicine and Preventive Medicine, University of Wisconsin, Madison.
REFERENCES
1. Institute of Medicine. Sleeping Pills, Insomnia, and Medical Practice. Washington, DC: National Academy of Sciences; 1979.
2. Mellinger G, Balter M, Uhlenhuth E. Insomnia and its treatment: prevalence and correlates. Arch Gen Psychiatry. 1985;42:225-232.
FREE FULL TEXT
3. Belloc N. Relationships of health practices and mortality. Prev Med. 1973;2:67-81.
FULL TEXT
| PUBMED
4. Wiley J, Camacho T. Life-style and future health: evidence from the Alameda County Study. Prev Med. 1980;9:1-21.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
5. Ford D, Kamerow D. Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention? JAMA. 1989;262:1479-1484.
FREE FULL TEXT
6. Eaton W, Badawi M, Melton B. Prodromes and precursors: epidemiologic data for primary prevention of disorders with slow onset. Am J Psychiatry. 1995;152:967-972.
WEB OF SCIENCE
| PUBMED
7. Kennedy G, Kelman H, Thomas C. Persistence and remission of depressive symptoms in late life. Am J Psychiatry. 1991;148:174-178.
WEB OF SCIENCE
| PUBMED
8. Regestein Q. Sleep disorders in the medically ill. In: Stoudemire A, Fogel BS, eds. Principles of Medical Psychiatry. Orlando, Fla: Grune & Stratton; 1987:271-302.
9. Kuppermann M, Lubeck D, Mazonson P, et al. Sleep problems and their correlates in a working population. J Gen Intern Med. 1995;10:25-32.
WEB OF SCIENCE
| PUBMED
10. Katz D, McHorney C. The impact of insomnia on quality of life in patients with chronic illness. Med Decis Making. 1996;16:455.
11. Leger D. The cost of sleep-related accidents: a report for the national commission on sleep disorders research. Sleep. 1994;17:84-93.
WEB OF SCIENCE
| PUBMED
12. Shapiro C, Dement W. Impact and epidemiology of sleep disorders. BMJ. 1993;306:1604-1607.
13. Wetzler H, Cruess D. Self-reported physical health practices and health care utilization: findings from the National Health Interview Survey. Am J Public Health. 1985;75:1329-1330.
WEB OF SCIENCE
| PUBMED
14. Weyerer S, Dilling H. Prevalence and treatment of insomnia in the community: results from the upper Bavarian field study. Sleep. 1991;14:392-398.
WEB OF SCIENCE
| PUBMED
15. Gislason T, Almqvist M. Somatic diseases and sleep complaints. Acta Med Scand. 1987;221:475-481.
WEB OF SCIENCE
| PUBMED
16. Klink M, Quan S, Kaltenborn W, Lebowitz M. Risk factors associated with complaints of insomnia in a general adult population. Arch Intern Med. 1992;152:1634-1637.
FREE FULL TEXT
17. Soldatos C. Insomnia in relation to depression and anxiety: epidemiologic considerations. J Psychosom Res. 1994;38:3-8.
18. Blazer D, Hays J, Foley D. Sleep complaints in older adults: a racial comparison. J Gerontol A Biol Sci Med Sci. 1995;50:M280-M284.
19. Hyyppa M, Kronholm E. Quality of sleep and chronic illnesses. J Clin Epidemiol. 1989;42:633-638.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
20. Stewart A. Measuring Functioning and Well-being. Durham, NC: Duke University Press; 1992.
21. Tarlov A, Ware J, Greenfield S, Nelson E, Perrin E, Zubkoff M. The Medical Outcomes Study: an application of methods for monitoring the results of medical care. JAMA. 1989;262:925-930.
FREE FULL TEXT
22. Stewart A, Greenfield S, Hays R, et al. Functional status and well-being of patients with chronic conditions: results from the Medical Outcomes Study. JAMA. 1989;262:907-913.
FREE FULL TEXT
23. Wells K, Stewart A, Hays R, Burnam M, Rogers W. Detection of depressive disorder for patients receiving prepaid or fee-for-service care: results from the Medical Outcomes Study. JAMA. 1989;262:3298-3302.
FREE FULL TEXT
24. Kravitz R, Greenfield S, Rogers W, Manning W, Zubkoff M. Differences in the mix of patients among medical specialties and systems of care: results from the Medical Outcomes Study. JAMA. 1992;267:1617-1623.
FREE FULL TEXT
25. Wells K, Stewart A, Hays R, Burnam M, Rogers W. The functioning and well-being of depressed patients: results from the Medical Outcomes Study. JAMA. 1989;262:914-919.
FREE FULL TEXT
26. Burnam M, Wells K, Leake B, Landsverk J. Development of a brief screening instrument for detecting depressive disorders. Med Care. 1988;26:775-789.
WEB OF SCIENCE
| PUBMED
27. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition. Washington, DC: American Psychiatric Association; 1980.
28. Wells K, Burnam M, Rogers W, Hays R, Camp P. The course of depression in adult outpatients: results from the Medical Outcomes Study. Arch Gen Psychiatry. 1992;49:788-794.
FREE FULL TEXT
29. Haley S, McHorney C, Ware J. Evaluation of the MOS SF-36 physical functioning scale (PF-10): unidimensionality and reproducibility of the Rasch item scale. J Clin Epidemiol. 1994;47:671-684.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
30. McHorney C, Ware J, Raczek A. The MOS 36-item short-form health survey (SF-36), II: psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31:247-263.
WEB OF SCIENCE
| PUBMED
31. McHorney C, Ware J, Lu J, Sherbourne C. The MOS 36-item short-form health survey (SF-36), III: tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994;32:40-66.
WEB OF SCIENCE
| PUBMED
32. Hays R, Stewart A. Sleep measures. In: Stewart A, Ware J, eds. Measuring Functioning and Well-being: The Medical Outcomes Study Approach. Durham, NC: Duke University Press; 1992.
33. Bixler E, Kales A, Soldatos C. Prevalence of sleep disorders in the Los Angeles metropolitan area. Am J Psychiatry. 1979;136:1257-1262.
WEB OF SCIENCE
| PUBMED
34. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
35. Hays R, Wells K, Sherbourne C, Spritzer K. Functioning and well-being outcomes of patients with depression compared with chronic general medical illness. Arch Gen Psychiatry. 1995;52:11-19.
FREE FULL TEXT
36. Ware J, Bayliss M, Rogers W, Kosinski M, Tarlov A. Differences in 4-year health outcomes for elderly and poor, chronically ill patients treated in HMO and fee-for-service systems. JAMA. 1996;276:1039-1047.
37. Moran M, Stoudemire A. Sleep disorders in the medically ill patient. J Clin Psychiatry. 1992;53:29-36.
38. Hosmer D, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons Inc; 1989.
39. Kravitz R, Greenfield S, Rogers W, Manning W, Zubkoff M. Differences in the mix of patients among medical specialties and systems of care. JAMA. 1992;267:1617-1623.
40. StataCorp. Stata Statistical Software. Release 4.0 ed. College Station, Tex: Stata Corp; 1995.
41. Rodin J, McAvay G, Timko C. A longitudinal study of depressed mood and sleep disturbances in elderly adults. J Gerontol. 1988;43:P45-P53.
42. Wooten V. Medical causes of insomnia. In: Kryger M, Roth T, Dement W, eds. Principles and Practice of Sleep Medicine. Philadelphia, Pa: WB Saunders Co; 1989:456-475.
43. Hohagen F, Rink K, Kappler C, et al. Prevalence and treatment of insomnia in general practice. Eur Arch Psychiatry Clin Neurosci. 1993;242:329-336.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
44. Bliwise D, King A, Harris R, Haskell W. Prevalence of self-reported poor sleep in a healthy population aged 50-65. Soc Sci Med. 1992;34:49-55.
45. Asplund R. Sleep and hypnotics among the elderly in relation to body weight and somatic disease. J Intern Med. 1995;238:65-70.
WEB OF SCIENCE
| PUBMED
46. Barry J, Campbell S, Yeung A, Khether E, Selwyn A. Waking and rising at night as a trigger of myocardial ischemia. Am J Cardiol. 1991;67:1067-1072.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
47. Moran M, Stoudemire A. Sleep disorders in the medically ill patient. J Clin Psychiatry. 1992;53:29-36.
48. Koskenvuo M, Kaprio J, Partinene M, Langinvainio H, Sarna S, Heikkila K. Snoring as a risk factor for hypertension and angina pectoris. Lancet. 1985;1:893-896.
WEB OF SCIENCE
| PUBMED
49. Partinen M, Kaprio J, Koskenvuo M, Langinvainio H. Sleeping habits, sleep quality and use of sleeping pills: a population study of 31,140 adults in Finland. In: Guilleminault C, Lugaresi E, eds. Sleep/Wake Disorders. New York, NY: Raven Press; 1983.
50. Alonso J, Anto J, Gonzalez M, et al. Measurement of general health status of non–oxygen-dependent chronic obstructive pulmonary disease patients. Med Care. 1992;30:MS125-MS135.
51. Klink M, Dodge R, Quan S. The relation of sleep complaints to respiratory symptoms in a general population. Chest. 1994;105:151-154.
FREE FULL TEXT
52. Cormick W, Olson L, Hensley M, Saunders N. Nocturnal hypoxaemia and quality of sleep in patients with chronic obstructive pulmonary disease. Thorax. 1986;41:846-854.
FREE FULL TEXT
53. Montplaisir J, Walsh J, Malo J. Nocturnal asthma: features of attacks, sleep and breathing patterns. Am Rev Respir Dis. 1982;125:18-22.
WEB OF SCIENCE
| PUBMED
54. Brown S, Salive M, Pahor M, Foley D. Occult caffeine as a source of sleep problems in an older population. J Am Geriatr Soc. 1995;43:860-864.
WEB OF SCIENCE
| PUBMED
55. Leigh T, Hindmarch I, Bird H, Wright V. Comparison of sleep in osteoarthritic patients and age and sex matched healthy controls. Ann Rheum Dis. 1988;47:40-42.
FREE FULL TEXT
56. Middelkoop H, Smilde-van den Doel DA, Knuistingh N, Kamphuisen H, Springer C. Subjective sleep characteristics of 1,485 males and females aged 50-93: effects of sex and age, and factors related to self-evaluated quality of sleep. J Gerontol. 1996;51:M108-M115.
57. Pressman M, Figueroa W, Kendrick-Mohamed J, Greenspon L, Peterson D. Nocturia: a rarely recognized symptom of sleep apnea and other occult sleep disorders. Arch Intern Med. 1996;156:545-550.
FREE FULL TEXT
58. Goldsmith G, Levin J. Effect of sleep quality on symptoms of irritable bowel syndrome. Dig Dis Sci. 1993;38:1809-1814.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
59. Pressman M, Benz R, Schleifer C, Peterson D. Sleep disordered breathing in end stage renal disease: acute beneficial effects of treatment with nasal continuous positive airway pressure. Kidney Int. 1993;43:1134-1139.
WEB OF SCIENCE
| PUBMED
60. Benca R, Obermeyer W, Thisted R, Gillin C. Sleep and psychiatric disorders. Arch Gen Psychiatry. 1992;49:651-668.
FREE FULL TEXT
61. Roth T, Kramer M, Lutz T. The nature of insomnia: a descriptive summary of a sleep clinic population. Compr Psychiatry. 1976;17:217-220.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
62. Reite M, Buysse D, Reynolds C, Mendelson W. The use of polysomnography in the evaluation of insomnia. Sleep. 1995;18:58-70.
WEB OF SCIENCE
| PUBMED
63. Carskadon M, Dement W, Mitler M, Guilleminault C, Zarcone V, Spiegel R. Self-reports versus sleep laboratory findings in 122 drug-free subjects with complaints of chronic insomnia. Am J Psychiatry. 1976;133:1382-1388.
WEB OF SCIENCE
| PUBMED
64. Baekeland F, Hoy P. Reported vs recorded sleep characteristics. Arch Gen Psychiatry. 1971;24:548-551.
FREE FULL TEXT
65. Kupfer D, Reynolds C. Management of insomnia. N Engl J Med. 1997;336:341-346.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
66. Drugs for psychiatric disorders. Med Lett Drugs Ther. 1994;36:89-96.
WEB OF SCIENCE
| PUBMED
67. Bloom J, Kaltenborn W, Quan S. Risk factors in a general population for snoring. Chest. 1988;93:676-683.
FREE FULL TEXT
68. Phillips B, Danner F. Cigarette smoking and sleep disturbance. Arch Intern Med. 1995;155:734-737.
FREE FULL TEXT
69. Hla K, Young T, Bidwell T, Palta M, Skatrud J. Sleep apnea and hypertension: a population-based study. Ann Intern Med. 1994;120:382-388.
FREE FULL TEXT
70. Haponik E, Frye A, Richards B, Wymer A, Hinds A. Sleep history is neglected diagnostic information. J Gen Intern Med. 1996;11:759-761.
WEB OF SCIENCE
| PUBMED
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Nonpharmacologic Approaches to the Management of Insomnia
Lande and Gragnani
J Am Osteopath Assoc 2010;110:695-701.
ABSTRACT
| FULL TEXT
Alcohol and Sleep Problems in Primary Care Patients: A Report from the AAFP National Research Network
Vinson et al.
Ann Fam Med 2010;8:484-492.
ABSTRACT
| FULL TEXT
Prospective Associations of Insomnia Markers and Symptoms With Depression
Szklo-Coxe et al.
Am J Epidemiol 2010;171:709-720.
ABSTRACT
| FULL TEXT
Psychosocial Correlates of Insomnia Severity in Primary Care
Bluestein et al.
J Am Board Fam Med 2010;23:204-211.
ABSTRACT
| FULL TEXT
Poor sleep and impaired self-care: Towards a comprehensive model linking sleep, cognition, and heart failure outcomes
Riegel and Weaver
Eur J Cardiovasc Nurs 2009;8:337-344.
ABSTRACT
| FULL TEXT
Anger Expression and Sleep Quality in Patients With Coronary Heart Disease: Findings From the Heart and Soul Study
Caska et al.
Psychosom. Med. 2009;71:280-285.
ABSTRACT
| FULL TEXT
Sleep Disorders in Psychiatry
Becker
ACCP Sleep Med Brd Rev 2009;4:103-110.
FULL TEXT
Insomnia: Prevalence, Impact, Pathogenesis, Differential Diagnosis, and Evaluation
Becker
ACCP Sleep Med Brd Rev 2009;4:201-210.
FULL TEXT
Racial Differences in Sleep Medication Use: A Cross-Sectional Study of the Johnston County Osteoarthritis Project
Allen et al.
The Annals of Pharmacotherapy 2008;42:1239-1246.
ABSTRACT
| FULL TEXT
Indiplon: A Nonbenzodiazepine Sedative-Hypnotic for the Treatment of Insomnia
Marrs
The Annals of Pharmacotherapy 2008;42:1070-1079.
ABSTRACT
| FULL TEXT
C-reactive protein Levels and Sleep Disturbances: Observations Based on The Northern Finland 1966 Birth Cohort Study
Liukkonen et al.
Psychosom. Med. 2007;69:756-761.
ABSTRACT
| FULL TEXT
Sleep disturbances independently predict heart failure in overweight middle-aged men
Ingelsson et al.
Eur J Heart Fail 2007;9:184-190.
ABSTRACT
| FULL TEXT
Sleep and health: everywhere and in both directions.
Zee and Turek
Arch Intern Med 2006;166:1686-1688.
FULL TEXT
Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation.
Irwin et al.
Arch Intern Med 2006;166:1756-1762.
ABSTRACT
| FULL TEXT
Insomnia, trouble sleeping, and complementary and alternative medicine: analysis of the 2002 national health interview survey data.
Pearson et al.
Arch Intern Med 2006;166:1775-1782.
ABSTRACT
| FULL TEXT
Sleep Disturbance and Obesity: Changes Following Surgically Induced Weight Loss
Dixon et al.
Arch Intern Med 2001;161:102-106.
ABSTRACT
| FULL TEXT
SF-36: Evaluation of Quality of Life in Severe and Mild Insomniacs Compared With Good Sleepers
Leger et al.
Psychosom. Med. 2001;63:49-55.
ABSTRACT
| FULL TEXT
Conundrums in Sleep Medicine
Collop
Chest 1999;115:607-608.
FULL TEXT
|
